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Epidemiological and clinical studies have linked exposure to particulate matter (PM) to adverse health effects, which may be
registered as increased mortality and morbidity from various cardiopulmonary diseases. Despite the evidence relating PM to
health effects, the physiological, cellular, and molecular mechanisms causing such effects are still not fully characterized. Twomain
approaches are used to elucidate the mechanisms of toxicity. One is the use of in vivo experimental models, where various effects
of PM on respiratory, cardiovascular, and nervous systems can be evaluated. To more closely examine the molecular and cellular
mechanisms behind the different physiological effects, the use of various in vitromodels has proven to be valuable. In the present
review, we discuss the current advances on the toxicology of particulate matter and nanoparticles based on these techniques.
1. Introduction
Exposure to particulate matter (PM) is associated with
increases in visits to emergency rooms and mortality [1].
The Meuse valley fog of 1930 [2], the Donora smog incident
of 1948 [3], and the London great smog event of 1952 [4]
triggered the studies of health effects related to the exposure
to PM in large cities and later on the legislation regarding the
level limits of PM. For instance, in the US, the Clean Air Act
was enacted in 1972.
Inhaled particles penetrate into the respiratory tract
where they target different anatomical sites, depending
among other properties on the aerodynamic size. Particles are
categorized according to aerodynamic size, PM
10
, thoracic
particles, (≤10 𝜇m) and PM
2.5
(≤2.5 𝜇m), or fine fraction.
The particles with a range of aerodynamic sizes between 10
and 2.5 𝜇m (PM
10-2.5) are know as coarse fraction. If the
aerodynamic size is equal or less than 0.1 𝜇m, the particles are
called ultrafine particles (UFP), and one of the main sources
of this type of primary particles is diesel exhaust (DEP).
Engineered particles, measured by their geometric size and
with at least one dimension smaller than 0.1𝜇m, are known
as nanoparticles (NP) [5]. The primary anatomical target of
particles with different sizes is summarized on Figure 1.
Air Quality Standards have been adopted by many
countries around the world to protect public health and
welfare against the adverse effects of air pollution. In fact,
member countries of theWorldHealth Organization (WHO)
have adopted a constitution that sets guidelines on air
pollutants. The WHO, which has representation from nearly
200 countries, recommends daily PM
10
concentrations not to
exceed 50 𝜇g/m3 [6]. Many countries, however, have chosen
to set Air Quality Standards that are more relaxed or more
stringent than the WHO Standard. Air Quality Standards
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Figure 1: Schematization of the size and main target for particulate matter and nanoparticles.
are generally created or revised according to national policy
and scientific information that demonstrates a plausible
association between health-related illnesses and exposure to
pollutants. The limits for PM
10
and PM
2.5
that are used in
different countries and regions are shown inTable 1 (Modified
from [6]).
Despite all the efforts for measuring the health impact
of inhaled particulate matter, we are still far from fully
understanding all the effects andmechanisms related to those
effects, and also, we still do not understand what is the role
of the length (size), shape, and composition of particles in
their biological effects. In the present paper, we reviewed
the relevant information related to three main aspects of the
problem: (1) the determination and role of the chemical and
biological components of particles, (2) the evaluation of the
in vivo effects, both at pulmonary and systemic targets, and
(3) the evaluation of the mechanisms of the cellular effects
of particles with different sizes, shapes, and composition.
Among the large amount of articles that are published in
these fields, we choose those that we consider are helping
to understand the different problems and also those articles
that are opening new questions, pushing the limits of our
knowledge forward.
2. Characterization of Particles
Combustion particles from traditional fuels (biomass, coal,
wood, crude oil, and diesel with high content in sulfur) are
now found in much lower concentrations in air than 30–
40 years ago due to improved and cleaner technology. The
relative size distribution has changed, and other pollutants
have gained prominence, such as ultrafine PM (UFP) [7].
These new and lighter airborne PM is found not only in big
cities but also in large and small towns. Interestingly, they
differ in composition with regard to various heavy metals
and polycyclic aromatic hydrocarbons (PAHs) and are often
found to have a higher oxidative and toxic potentials.
Depending on the source and composition of the PM
different subsets of components may be found on different
fractions. PM
2.5
comprises the soot fraction and particles
grown from the gas phase with subsequent agglomera-
tion. PM
2.5
includes inorganic ions such as sulfate, nitrate,
and ammonia, as well as combustion-form carbon, organic
aerosols, metals, and other combustion products. PM
10-2.5
is dominated by mechanically abraded or ground particles
including finely dividedminerals such as oxides of aluminum
silicate, iron, calcium, and potassium [8].
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Table 1: Comparison of the WHO guidelines and standards from
different countries. Modified from WHO air quality guidelines,
global update, 2005, a report on a Working Group meeting, Bonn,
Germany, 18–20 October 2005 [5].
Selected air quality guidelines and standards
Source PM10 (𝜇g/m
3) PM2.5 (𝜇g/m
3)
1 year 24 hours 1 year 24 hours
WHO [2] 20 50 10 25
European Union 40 50 25
United States 50 150 12 35
California 20 50 15 65
Japan 100 12 65
Brazil 50 150
Mexico 50 120 15 65
South Africa 60 180 15 65
India (sensitive
populations/
residential/industrial)
50/60/120
China
(Classes I/II/III) 40/100/150 50/150/250 35
UFPs are composed of both primary and secondary
particulate matters [9].The primary fraction is the one that is
emitted directly from the emission sources and often includes
agglomerate/aggregates of smaller particles [9]. Their size is
generally in the range between 30 and 100 nm [10, 11].The pri-
mary fraction is generally associated with diesel engines and
automobiles and biomass combustion which are thought to
initially have been emitted at around the 30 nm diameter size
(the so called nucleation mode) and later coagulate into the
larger fraction of the ultrafine mode. The secondary fraction
is composed of particulate matter formed in the atmosphere
and includes sulfuric acid and sulfates and organic reaction
products of low volatility [9]. Photoreactions of oxides of
nitrogen (NOx) and sulfur dioxide (SO
2
) are involved in
this process; both of which are products of combustion.
This fraction size is generally in the range between 100 and
200 nm, which is partially distinguishable from other directly
anthropogenic sources.
The role of composition on toxic effects has been explored
during the last decade by different authors.Thedogma during
the 1990’swas that the size of the particlewas the predominant
factor of toxicity, the smaller particles being the more toxic
[12]. Nevertheless, during the last 15 years, evidence has
linked surface area, reactivity, and different components of
the particles with their toxicity [13–15]. The first efforts
were done by collecting samples from associated to different
sources such as indoor and outdoor [16], different cities [17],
or regions within a large city [18] and comparing their in vitro
toxic effects. In some cases, partial chemical characterizations
or determinations of the presence of some components
were empirically related with differences in the intensity of
toxic effects [19–21]. Later on, comprehensive characteriza-
tions were correlated using different statistical models [13–
15]. Currently, the characterization of size, physicochemi-
cal, and chemical composition is necessary to understand
the toxicology of particles. For instance, for nanoparticles
(NP), the determination of particle size, the dynamics of
agglomeration and aggregation, the area, and the charge are
mandatory for any toxicological evaluation [22]. In the field of
urban particles, considering that they are complex mixtures,
there are no standard measurements of physicochemical and
chemical components, but the determination of total carbon,
black carbon, transitional metals, nitrates, sulfates, oxidative
potential, and polycyclic aromatic hydrocarbons is among the
most evaluated components [23, 24]. A recent report of a
meta-analysis and multisite time series evaluating elemental
carbon, organic carbon matter, sulfate, and nitrate on PM
2.5
and in its relation to hospital admissions demonstrates that
changes in elemental carbon content are associated with car-
diovascular hospital admissions [25]. The authors conclude
that a stronger communication between risk assessors and
epidemiologist would help to better understand the role of
the components of air pollutants on population effects.
Among the many components that are present in PM,
the biological components seem to play a central role in
the biological effects. There is increasing evidence that when
PM is inhaled the biological component is responsible for
stimulating alveolar macrophages and respiratory epithelial
tissue to release proinflammatory cytokines and chemokines.
The biological components may also have synergetic effects
with other components of the PM, such as diesel exhaust
enhancing IgE production and thus facilitating allergic sen-
sitization [26].
These biological components may be released by passive
or active mechanisms from plants, soil, biofilms, solid, or
liquid sources to become suspended in the air. The measure-
ment of protein associated with PM is considered as a general
indicator of how much of the PM comes from a biological
source. It represents about 1–4% of the total mass of PM
10
for
urban and rural areas [27, 28].
Airborne biological particles or dust containing bio-
logical agents and/or substances of biological origin are
important components of the coarse and fine PM. These
components are represented by different types of primary or
secondary (fragmented biological cells) biological aerosols
[29]. The biological matter is predominantly comprised by
plant pollen, spores, and microorganisms (mold and bacte-
ria) or microbial metabolites [30, 31] and is related to allergic,
toxic, and infectious responses in exposed individuals.
PM may be an efficient carrier of secondary allergens
or proinflammatory compounds [32–34]. Recently, good
correlation has been found for major allergens, mainly from
pollen, and asthmatic patients. In fact, pollen from grasses,
weeds and trees, among others were found onto different
size of particles [35]. Most of the primary allergens (intact
pollen, 10–100 𝜇m) cannot reach the small airways; however,
the secondary pollen allergens present in PM
2.5
can easily
penetrate there [36].
Endotoxin lipopolysaccharides (LPSs) are other proin-
flammatory compounds from microbial origin present in
PM. Endotoxin is a component of the cell wall of gram-
negative bacteria, and its main source is debris deposited on
urban or rural soil.When the LPS is resuspended and inhaled,
it stimulates alveolar macrophages and respiratory epithelial
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Figure 2: Schematization of the main acute, subacute, and chronic effects induced by inhaled particles and nanoparticles. In the acute side
it is interesting to highlight that a high-caloric- and fat-rich diet provides a scenario facilitating proinflammatory effects of particles. Also,
Tnymoquinone, eugenol, simstatin, and lovastin have a protective effect in vivo. In the subacute and chronic side, it is interesting to highlight
the presence of tissue alterations, lung infiltration by T cells, and increases in the risk of COPD.
tissue to release cytokines/chemokines, initiating an inflam-
matory cascade [37, 38]. Another biological component with
similar effects is the 𝛽-1,3-Glucan, a glucose polymer which is
structural component of most fungal cell walls. 𝛽-1,3-Glucan
has been used as an indicator of the presence ofmold [39, 40].
3. In Vivo Studies
Themain target for inhaled particles is the respiratory system,
but there is strong evidence that systemic effects can be
induced.We are presenting some of the most relevant studies
regarding the local and systemic effects induced by inhaled
particles. In Figure 2, we summarize some of the most
relevant acute, subacute, and chronic effects induced in vivo
by particles.
3.1. Respiratory Effect of Particles
3.1.1. Acute Effects. Several studies have investigated the res-
piratory effects of particulate air pollution and nanoparticles.
While most of the studies have focused on the respiratory
effects following inhalation, intratracheal or intranasal instil-
lation, others have investigated the effects of intravenous,
intraperitoneal, or oral administration.
It is well established that pulmonary exposure to partic-
ulate air pollution causes inflammation and oxidative stress
[41–43]. It has been demonstrated that acute (within 24 h),
single-dose intratracheal instillation of diesel exhaust parti-
cles (15–30 𝜇g/mouse), a relevant type of PM
2.5
, causes lung
inflammation characterized by influx of inflammatory cells,
increases total proteins, a marker of epithelial permeability,
and oxidative stress [41, 42]. The release of interleukin-6
(IL-6) was found to increase in bronchoalveolar lavage (BAL)
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fluid at 18 h but not at 4 or 24 h [42]. Similarly, at 18 h time
point, airway resistance tomethacholinemeasured invasively
using forced oscillation technique increased significantly and
dose-dependently following exposure to DEP [42]. Pretreat-
ment with thymoquinone, a constituent of Nigella sativa,
ameliorated DEP-induced pulmonary effects [42].
Acute exposure (24 h) of healthy mice by intranasal
instillation to PM
2.5
(5 or 15 𝜇g/mouse) collected from the
urban area of Sao Paulo caused lung inflammation and
oxidative stress and worsened lung impedance in dose-
dependent pattern [44]. The same research group has more
recently reported that pretreatment of mice with eugenol,
a methoxyphenol component of clove oil with anti-inflam-
matory and antioxidant properties, prevented the changes
in lung mechanics, pulmonary inflammation, and alveolar
collapse elicited by acute exposure to DEP [45].
The statins are hydroxy-methyl-glutaryl-CoA reductase
inhibitors, broadly used in the treatment of hyperlipidemia.
They play a key role in the primary and secondary prevention
of atherosclerotic heart disease and stroke. Moreover, they
have been reported to have potential benefits for a variety of
other cardiovascular and noncardiovascular diseases, includ-
ing cancer, respiratory and neurological disorders [46, 47].
Interestingly, Ferraro and coworkers [48] reported that resid-
ual oil fly ash (ROFA) and Urban Air Particle (UAP) from
Buenos Aires produced an acute pulmonary injury in mice,
characterized by a neutrophilic inflammation, a rise in O
2
−
generation, and production of the proinflammatory tumour
necrosis alpha (TNF𝛼) cytokine. Simvastatin pretreatment
had no significant effect per se on any of these biomarkers
but prevented the pulmonary cytotoxicity and inflammation
induced by ROFA and UAP. More recently, Miyata and
coworkers [49] found that pulmonary exposure to PM
10
in rabbits accelerated the turnover of polymorphonuclear
leukocytes (PMNs) by shortening their transit time through
themarrow. Interestingly, they found that lovastatin dampens
these systemic responses by decreasing the levels of PM
10
-
induced circulatingmediators (IL-6), thereby suppressing the
bone marrow stimulation. The effect of statins was predom-
inant on PMNs in the postmitotic pool as evident by the
use of 5󸀠-bromo-2󸀠-deoxyuridine (BrdU/G3). Interestingly,
statins also reduced the retention of these newly released
PMNs in the lung tissues. These results corroborate the
previous finding from the same research group reporting
that PM
10
particles induced systemic inflammatory responses
characterized by an increase in systemic proinflammatory
mediators such as IL-6 [50].
The metabolism of L-arginine plays an important home-
ostatic role in the airways, through synthesis of the bron-
chodilating molecule, nitric oxide (NO), from L-arginine,
by the nitric oxide synthase (NOS) isozymes. The arginase
isozymes (arginases 1 and 2) convert L-arginine into L-
ornithine and urea and thus compete with the NOS isozymes
for substrate. Arginase overexpression contributes to airways
hyperresponsiveness in asthma, and its expression is further
augmented in cigarette smoking asthmatics [51]. It has been
recently reported that arginase is upregulated following
exposure to O
3
and concentrated ambient particles inmurine
models of asthma and contributes to the pollution-induced
exacerbation of airways responsiveness [52].
The question, whether a diet challenge increases the
inflammatory response in the alveolar and the blood com-
partment in response to carbon nanoparticles (CNP) was
investigated by Go¨tz and coworkers [53]. In their study,
mice were fed a high-caloric carbohydrate-rich or a fat-rich
diet for six weeks and were compared to mice kept on a
purified low fat diet, respectively. Bronchoalveolar lavage
(BAL) and blood samples were taken 24 h after intratracheal
CNP instillation and checked for cellular and molecular
markers of inflammation. The authors reported an increase
in BAL proinflammatory factors in high-caloric groups and
reductions in serum concentrations of anti-inflammatory
factors in fat-rich group. They concluded that extended
feeding periods, leading to manifest obesity, are necessary
to generate an increased susceptibility to particle-induced
lung inflammation, although the diet challenge already was
efficient in driving proinflammatory systemic events.
Barlow and coworkers [54] assessed the effects of intratra-
cheally instilled PM
10
collected from London onmacrophage
clearance in rats ex vivo. These authors concluded that acute
PM
10
exposure has an effect on macrophage phagocytosis
and chemotaxis that may be deleterious to particle clearance
within the alveolar region of the lung.The decrease in chemo-
tactic ability may represent one mechanism that promotes
inflammation after increases in ambient PM levels. They also
concluded that further investigation is warranted to deter-
mine the effects of chronic PM
10
exposure on macrophage
clearance mechanisms.
NPs induce inflammatory responses and oxidative stress
but may also have immune-suppressive effects, impairing
macrophage function and altering epithelial barrier func-
tions. The question related to whether exposure to NP may
increase the risk of pulmonary infection has been recently
investigated [55]. It has been demonstrated that Cu NP expo-
sure impaired host defense against bacterial lung infections
and induced a dose-dependent decrease in bacterial clearance
[55]. Moreover, it has been demonstrated that acute exposure
to DEP by inhalation exacerbates lung inflammation induced
by lipopolysaccharide [56].
In an interesting study, the impact of pulmonary exposure
to carbon black NP on emphysematous lung injury induced
by porcine pancreatic elastase (PPE) was investigated in
mice [57]. It has been demonstrated that carbon black
NP exacerbates PPE-induced pulmonary inflammation and
emphysema. This enhancement may be mediated, at least
partly, via the increased local expression of proinflammatory
molecules.
TiO
2
nanoparticles have several industrial applications,
and, as such, also have different sizes, shapes, chemistry, and
crystalline structures [58, 59]. TiO
2
occurs in four crystalline
polymorphs of which rutile and anatase are most common
[60]. Rutile is considered as a more inert form, whereas
anatase is an active form of TiO
2
. Anatase and rutile TiO
2
particles, delivered at similar surface area doses, increased
release of lactate dehydrogenase, interleukin-8, and reactive
oxygen species, as well as depressed mitochondrial activity
in dissimilar patterns in cultured human epithelial cells [61].
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In vivo, it was observed that ultrafine anatase TiO
2
particles
produced increases in bronchoalveolar lavage inflammatory
indicators, cell proliferation, and histopathology compared
to ultrafine rutile TiO
2
particles [62]. However, with both
crystalline forms of TiO
2
particles, pulmonary effects were
observed at 24 h and resolved by oneweek after exposure [62].
Furthermore, it has also been demonstrated that the intratra-
cheal instillation of rutile TiO
2
nanorods caused upregulation
of lung and systemic inflammation and triggered platelet
aggregation [63].
TiO
2
-based photocatalysis has attracted extensive interest
because of its great advantages in the completemineralization
of organic pollutants in waste water and air [64, 65]. As a
popular photocatalyst, TiO
2
has been widely studied because
of its various merits, such as optical-electronic properties,
low cost, and chemical stability. Characteristics of TiO
2
nanoparticles can bemodified by several methods to improve
their performance. In this context, TiO
2
nanorods are doped
with iron in order to increase their photocatalytic activity [63,
64]. It has been recently demonstrated that exposure to SiO
2
-
coated rutile TiO
2
nanoparticles (cnTiO
2
) caused pulmonary
neutrophilia, increased expression of tumor necrosis factor-
alpha (TNF𝛼) and neutrophil-attracting chemokine CXCL1
in the lung tissue. Uncoated rutile and anatase as well as
nanosized SiO
2
did not induce significant inflammation [66].
More recently, pulmonary exposure to well-characterized
rutile Fe-TiO
2
promotes pulmonary and systemic inflam-
mation and oxidative stress. It also enhances thrombotic
potential, heart rate, and systolic blood pressure (SBP) and
induces hepatotoxicity. Moreover, rutile Fe-TiO
2
showed
direct toxicity on human lung cancer cells NCI-H460-Luc2
and human hepatoma cells HepG2 [67].
3.1.2. Subacute and Chronic Effects. It has been demonstrated
that rats exposed for 6 months to urban air pollution
developed secretory cell hyperplasia in the airways and
ultrastructural ciliary alterations of the epithelium of the
airways, suggesting that chronic exposure to urban levels of
air pollution may cause respiratory alterations [68]. More-
over, rats submitted to prolonged exposure to low levels of
air pollution experienced deteriorated respiratory defenses
against infectious agents [69]. Recently, it has been reported
that intranasal instillation of DEP over 60 days increased the
expression ofMuc5ac in the lungs and the acidmucus content
in the nose compared with the 30-day treatment. Moreover,
DEP exposure enhanced the total leukocytes in the BAL and
the nasal epithelium thickness compared to saline-treated
control group [70].
Chronic exposure to PM
2.5
resulted in prominent inflam-
matory responses in the lung typified by increased levels
of oxidized phospholipid derivatives as well as a systemic
inflammatory response [71]. In a subsequent study, the same
group has extended some of their observations and reported
that exposure to PM
2.5
resulted in increased T-cell infiltration
and increased activation of T-effector cells (evidenced by
an increase in CD4+CD44+CD62L− and CXCR3+ T cells in
the lungs) and suggests a phenotypic switch to a Th1/Th17
phenotype in lung Teff cells. These results have important
implications for how PM
2.5
may detrimentally modulate
pulmonary and systemic immune responses [72].
Chronic obstructive pulmonary disease (COPD) is char-
acterized by not fully reversible airflow obstruction that
is usually progressive and associated with an abnormal
inflammatory response of the lung to noxious particles or
gases. The major etiological factor for COPD is chronic
oxidative stress as a result of long-term smoking, use of
biomass fuels, and air pollution exposure [73]. Lopes and
coworkers recently reported a study in which the effects of
chronic exposure (2 months) to ambient levels of PM on
development of protease (papain) induced emphysema and
pulmonary remodeling were investigated in mice [74]. They
found that mean linear intercept and the total amount of
collagen fibers in parenchymawere significantly greater in the
lungs of mice that were treated with papain and exposed to
ambient particles compared to thosemice treatedwith papain
and exposed to filtered air for 2 months. These increases in
destruction of lung parenchyma and in lung collagen content
observed only in the group of mice treated with papain and
exposed to ambient particles were associated with an increase
in the amount of 8-isoprostane expression in lung tissue,
suggesting that the increase in oxidative stress is a possible
mechanism to explain these alterations [74].
Different types of NPs can cause various inflamma-
tory reactions in the lung. In mice lungs, the toxicity of
single-wall carbon nanotube (SWCNT) in causing epithelioid
granulomas and interstitial inflammation 7 and 90 days
after intratracheal instillation has been shown to be greater
as compared with other NPs, like carbon black or quartz
particles [75]. However, the significance of the SWCNT-
induced inflammation has been a matter of scientific debate.
Initially it has been reported that intratracheally instilled
SWCNT in rats causes discrete granulomas that were not
dose-responsive, and an absence of signs of inflammation
in BAL suggested the possibility that large agglomerates of
SWCNT caused the granulomas [76]. A second study in rats,
using SWCNT aspiration, also reported slight change in the
differentials of BAL and a relative lack of histopathologic
evidence of inflammation [77]. Studies in mice demonstrated
significant inflammation, confirmed that SWCNT-induced
inflammation was often granulomatous, and, most impor-
tantly, demonstrated that inflammation was present whether
the SWCNTs were inhaled or aspirated [75, 78]. It was
concluded that SWCNT inhalation was more effective than
aspiration in causing inflammatory response, oxidative stress,
collagen deposition, and fibrosis as well as mutations of K-
ras gene locus in the lung of C57BL/6 mice [79]. Similarly
to SWCNT, multiple wall carbon nanotube (MWCNT) expo-
sures by inhalation at concentrations of 5mg/m3 or less for
14 days produced slight evidence of pulmonary inflammation
but suppressed T-cell-dependent immune functions [80].
However, the intratracheal instillation of shorter MWCNT
failed to show the occurrence of inflammation or fibrosis
[81]. Recently, it has been demonstrated that inhalation of
MWCNTs for up to 13 weeks caused granulomatous inflam-
mation and pleural thickening at exposure concentrations
greater than 6mg/m3. However, influx of inflammatory cells
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in BAL fluid and interstitial fibrosis wereas demonstrated at
exposures above 0.4mg/m3 [82].
Pulmonary inflammation caused by NP may also result
in changes in membrane permeability, which in turn can
result in particle translocation beyond the lung and affecting
cardiovascular system [83]. Indeed, it has been shown that
NPs have the potential to enter the brain [84] and blood
circulation [85, 86] and subsequently other major organs
causing inflammation and oxidative stress in these organs.
3.2. Extrapulmonary Effects of Particles
3.2.1. Possible Mechanisms Involved. Despite the consistency
of the epidemiologic observations, the pathophysiological
mechanisms linking air pollution to adverse cardiovascular
events remain unclear. There are three primary hypotheses
that are being investigated to explain the extrapulmonary
effect of NP [87, 88], and in Figure 3, we summarize the main
mechanisms proposed for the systemic effects. The first one
relates the effect of particles to their ability to impact the auto-
nomic nervous system. Studies showed that particulate air
pollution exposure is associated with rapid changes in auto-
nomic nervous systembalance, favoring sympathetic nervous
system activation and parasympathetic withdrawal leading
to changes in the pattern of breathing, heart rate, and heart
rate variability. Decreased heart rate variability indicates the
existence of a state of cardiac autonomy dysfunction and is a
risk factor for sudden cardiac death because of arrhythmias
[89]. The mechanisms responsible for the increase of the
sympathetic drive remain unclear butmay involve activations
of pulmonary neural reflex arcs anddirect effects of pollutants
on cardiac ion channels [89]. Inhaled particles may affect
the cardiovascular system through inflammatory mediators
produced in the lungs and released into the circulation [87,
88]. It has been suggested that inhaled particles may lead to
systemic inflammatory response through the release of IL-
6, TNF𝛼 or histamine, and oxidative stress within the lungs
and/or systemically [87, 88].
Moreover, several studies have shown that nanoparticles,
owing to their small size, could avoid normal phagocytic
defenses in the respiratory system and gain access to the sys-
temic circulation and therefore to different extrapulmonary
sites [85, 86, 90–93]. The UFP can pass from the lungs
into the blood circulation in hamsters [86]. Others [91–94]
have also reported extrapulmonary translocation of UFPs
after intratracheal instillation or inhalation in other animal
species. However, the amount of UFPs that translocated into
blood and extrapulmonary organs differed amongst these
studies. It has also been shown that, following intranasal
delivery, polystyrene microparticles (1.1 𝜇m) can translocate
to tissues in the systemic compartment [95]. Recent studies
[96–98] have provided morphological data illustrating that
inhaled particles are transported into the pulmonary capillary
space, presumably by transcytosis. Recently, Elder et al. [91]
demonstrated that the olfactory neuronal pathway represents
a significant exposure route of central nervous system (CNS)
tissue to inhaled UFPs. These authors showed that, in rats,
which are obligatory nose breathers, translocation of inhaled
nanosized particles along neurons is a more efficient pathway
to the CNS than via the blood circulation across the blood-
brain barrier. They speculated that given that this neuronal
translocation pathway was also demonstrated in nonhuman
primates, it is likely to be operative in humans as well [84, 91].
In humans, the literature on the translocation of UFPs from
the lungs into the blood circulation is still conflicting [85, 99,
100]. However, given the deep penetration of nanoparticulate
matter into the alveoli and close apposition of the alveo-
lar wall and capillary network, such particle translocation
seems plausible either as a naked particle or after ingestion
by alveolar macrophages [98]. Naked particles have been
reported to be taken up (and/or adsorbed) by erythrocytes
[101] and can presumably be distributed to various organs.
The distribution of radiolabelled ultrafine carbon particles,
commonly known as “Technegas”, has been investigated after
their inhalation by nonsmoking healthy human volunteers
[85]. The size of the individualized particles was in the order
of 5 to 10 nm, as we confirmed by electron microscopy of the
particles. Radioactivity, which was largely particle-bound, as
assessed by thin layer chromatography, was detected in blood
already after 1 minute, reaching a maximum between 10 and
20min-, and remaining at this level up to 60min. Gamma
camera images showed substantial radioactivity over the liver
and other areas of the body. The presence of radioactivity in
the liver is compatible with an accumulation of particles in
Kupffer cells, as is known to occur with colloidal particles
[102]. More recently, Pe´ry and coworkers [103] developed a
physiologically based kinetic model for (99m) technetium-
labelled carbon nanoparticles (Technegas). The model was
designed to analyze imaging data obtained from the study of
Nemmar and coworkers [85]. It included different transloca-
tion rates and kinetics for free technetium and small and large
technetium-labelled particles.The authors concluded that the
percentage of small particles able to translocate was estimated
at 12.7% of total particles, whereas the percentage of unbound
technetium was estimated at 6.7% of total technetium
[103].
Nurkiewicz and coworkers have studied the effects of
inhaled particles and nanoparticles on systemic microvascu-
lar endothelium. First, they demonstrated that rats exposed
to ROFA or TiO
2
presented a reduction in their capacity
to respond to the Ca2+ ionophore A23187, which induce
arteriolar dilatation [104]. In other studies, the same group
has shown that exposure to ROFA or TiO
2
NP, by instillation
or inhalation, induce systemic microvascular dysfunction
[105, 106]. They also found that the nitric oxide (NO)
signaling seems to be involved in the endothelial systemic
effects of the particles [107].
3.2.2. Acute Effects. Several studies demonstrated that expo-
sure to UFP or DEP caused pulmonary inflammation and
prothrombotic events in ear vein of rats or femoral vein
and artery of hamsters [108–112]. Mutlu and coworkers [113],
showed that exposure to PM triggers IL-6 production by
alveolar macrophages, resulting in reduced clotting times,
intravascular thrombin formation, and accelerated carotid
artery thrombosis [113]. The occurrence of oxidative stress in
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Extrapulmonary toxicity
Via Target Effect
Olfactory neural pathway Autonomic nervous system
Inhalation Lungs Release of inflammatory mediators
i.e., IL-6, TNF𝛼, histamine
leading to systemic inflammation
Translocation of inhaled particles
Endothelium Systemic endothelial dysfunction
Erythrocytes
Liver and other organs
Circulation Prothrombotic effects
Changes in the breathing pattern
Heart rate variability ↓
Figure 3: Summary of the main systemic effects associated with particle exposure and the possible mechanisms related to those effects.
the DEP-induced acute thrombotic tendency in pial cerebral
venules, activation of circulating blood platelets, and lung
inflammation have been reported in mice [25]. Moreover,
the same authors showed that the antioxidant pretreatment
with cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid
prevented DEP-induced inflammatory and the resulting
thrombotic complications [25]. More recently, the acute (4
and 18 h) effects of DEP on pulmonary and cardiovascular
parameters and the protective effect of thymoquinone were
investigated in mice [41]. Four h after DEP administration,
there were no significant changes in the cells in BAL,
lung histology, or pulmonary function test. However, at
18 h after exposure, both lung inflammation and pulmonary
function were significantly affected. Conversely, at both 4 h
and 18 h,DEP caused systemic inflammation characterized by
leukocytosis, increased IL-6 concentration, and reduced SBP.
DEP reduced platelets number and aggravated pial arteriole
thrombosis. The addition of DEP (0.1–1𝜇g/mL) to untreated
blood induced platelet aggregation.The cardiovascular effects
observed at 4 h after DEP exposure did not appear to result
from pulmonary inflammation but possibly from the blood
translocation of DEP and/or their associated components
[41]. However, at 18 h, DEP-induced significant changes in
pulmonary and cardiovascular functions and caused lung
inflammation. Pretreatment with thymoquinone effectively
prevented DEP-induced cardiorespiratory toxicity [41].
It has been reported that TNF𝛼 is a strong agonist for
plasminogen activator inhibitor 1 (PAI-1) expression and has
been found to play an important role in PAI-1 regulation in a
variety of diseases. In amouse endotoxemiamodel, TNF𝛼has
been found to contribute to the lipopolysaccharide-induced
PAI-1 expression [114]. Budinger et al. [115] demonstrated
that ambient PM-induced upregulation of PAI-1 disappeared
upon treatment of mice with a TNF𝛼 inhibitor [115]. In line
with the later findings, it has been recently demonstrated
that repeated exposure to DEP-induced airway inflammation
and hyper-reactivity, systemic inflammation, increased SBP,
and accelerated coagulation. TNF𝛼 productionwas increased
both in BAL and plasma. Pretreatment with curcumin sig-
nificantly inhibited the release of TNF𝛼 and prevented the
respiratory and cardiovascular effects of DEP [116].
An important aspect of the epidemiological associations
between air pollution and eithermorbidity ormortality is that
the acute adverse effects appear to be most marked in people
with preexisting compromised cardiovascular function, such
as hypertension or diabetes [89]. To give credibility for
these observations, several experimental studies have been
designed to test whether and to what extent the effects of par-
ticulate air pollution are aggravated, using an animal model
of angiotensin II-induced hypertension. Indeed, exposure
particulate matter with diameter ≤2.5 𝜇m (PM
2.5
) was found
to potentiate angiotensin II-induced hypertension [117, 118].
In addition, PM
2.5
increased angiotensin II-induced cardiac
hypertrophy, collagen deposition, and cardiac and vascular
RhoA activation, suggesting that cardiovascular health effects
are indeed the results of particulate air pollution exposure
[118]. Evidence for exacerbation of thrombotic but not res-
piratory events was also reported in angiotensin II-induced
hypertension in mice [119, 120]. With respect to diabetes
mellitus, it has been shown that DEP equally increased
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airway resistance and caused infiltration of inflammatory
cells in the lung of both diabetic and nondiabetic mice.
However, the occurrence of oxidative stress, the presence
of lung apoptotic cells, and the increase of total proteins,
albumin and TNF𝛼 in BAL fluid were only seen in DEP-
exposed diabetic mice suggesting an increased respiratory
susceptibility to particulate air pollution [121]. Moreover, the
same research grouphas shown that systemic and coagulation
events are aggravated by diabetes in mice acutely exposed to
DEP [122]. These authors stated that they may be relevant to
the exacerbation of cardiovascular morbidity accompanying
particulate air pollution in diabetic patients.
Novel evidence that pulmonary deposition ofDEP poten-
tiates the renal, systemic, and pulmonary effects of cisplatin-
induced acute renal failure (ARF) has been recently reported
byNemmar and colleagues [123].These findings highlight the
importance of environmental factors such as particulate air
pollution in aggravating ARF.
Several studies have showed that nanoparticles, owing
to their small size, could avoid normal phagocytic defenses
in the respiratory system and gain access to the systemic
circulation and therefore to different extrapulmonary sites
[83, 84, 90–93, 103, 123]. To specifically determine the effect
of translocated particles, it has been recently demonstrated in
both normotensive and spontaneously hypertensive rats that
24 h following their systemic administration, DEP affected
blood pressure and caused pulmonary inflammation assessed
by BAL [124, 125]. In a subsequent study in rats, it has been
reported that i.v. administration of DEP (0.02mg/kg) caused
acute systemic effects mainly at 6 h and 18 h but not at 48 h or
168 h following particle exposure. While DEPs were found in
lungs, heart, liver and kidneys, the histopathological changes
were only seen in the lung. This implies that, at the dose
and time-points investigated, DEP can cause inflammation in
the lungs but not in other organs, suggesting that pulmonary
tissue is the predominant site for inflammation based on the
mode of delivery of DEP in this study [126]. Furthermore,
it has been shown that ultrafine TiO
2
induces acute lung
inflammation after i.p. administration and exhibits additive
or synergistic effects with LPS, at least partly, via activation
of oxidant-dependent inflammatory signaling and the NF-
kappaB pathway, leading to increased production of proin-
flammatory mediators [127]. Geys et al. [128] have investi-
gated the toxicity of quantum dots which have numerous
possible applications for in vivo imaging. QDs causedmarked
vascular thrombosis in the pulmonary circulation, especially
with carboxyl QDs. QDs were mainly found in lung, liver,
and blood.Thrombotic complications were abolished, and P-
selectin was not affected by pretreatment of the animals with
heparin.
3.2.3. Subacute and Chronic Effect. Akinaga and coworkers
[129] reported a study in which mice were continuously
exposed, since birth, in two open-top chambers (filtered
and nonfiltered for airborne particles ≤0.3 𝜇m) placed 20m
from a street with heavy traffic in downtown Sao Paulo,
24 h per day for 4 months. They found that air pollution
inducedmild but significant vascular structural alterations in
normal individuals, presented as coronary arteriolar fibrosis
and elastosis.
PM has been shown to cause significant decreasing
patterns of heart rate, body temperature, and physical activity
in mice lacking apolipoprotein (ApoE−/−) over 5 months
of exposure to concentrated ambient PM, with smaller and
nonsignificant change for C57 mice [130].
Sun and coworkers demonstrated that ApoE−/− mice
exposed to concentrated regional northeastern PM
2.5
for 6
months (6 h/day for 5 day/week) in conjunction with high-
fat chow potentiated plaque developmentmarkedly increased
vascular inflammation (CD68+ macrophage infiltration and
inflammatory nitric oxide synthase (iNOS) expression) and
vessel wall markers of oxidative stress [131]. Plaque pro-
gression was accompanied by alterations in vasomotor
tone, including decreased endothelial-dependent vasodila-
tory function and heightened vasoconstriction to adrenergic
stimuli. The same research group confirmed their findings
by another set of experiments which was performed using
an identical protocol of exposure but involving an apoE−/−
model and a double-knockout (DK) model of ApoE−/−
and low-density lipoprotein (LDL) receptor deficient mice
(DK mice) to concentrated ambient PM
2.5
for 6 h a day
for 5 days/week for up to 5 months. Although quantita-
tive measurements showed that PM
2.5
exposure increased
atherosclerotic lesions in the apoE−/− mice, changes pro-
duced by PM
2.5
in DK mice were not statistically signif-
icant [132]. In subsequent set of experiments, it has been
shown that chronic ambient exposure to PM
2.5
increased
tissue factor expression in macrophages and smooth muscle
cells in atherosclerosis [133]. They also reported specific
recruitment ofmonocytes intomicrocirculatory tissue niches
(i.e., adipocytes) in response to long-term PM
2.5
exposure
[134]. These experiments suggest a key role for PM
2.5
in the activation and mobilization of innate immune cell
populations.
Long-term cardiovascular effects of inhaled nickel
hydroxide NPs (nano-NH) in hyperlipidemic, ApoE−/− mice
were investigated by Kang and coworkers [135]. Mice were
exposed to nano-NH at either 0 or 79𝜇g Ni/m3, via a whole-
body inhalation system, for 5 h/day, 5 days/week, for either
1 week or 5 months. Inhaled nano-NH induced significant
oxidative stress and inflammation in the pulmonary and
extrapulmonary organs, indicated by upregulated mRNA
levels of antioxidant enzyme and inflammatory cytokine
genes; increased mitochondrial DNA damage in the aorta;
significant signs of inflammation in BAL fluid; changes in
lung histopathology; and induction of acute-phase response.
In addition, after 5-month exposures, nano-NH exacerbated
the progression of atherosclerosis in ApoE−/− mice [135].
Emmerechts and coworkers have investigated how
continuous traffic-related air pollution exposure affects
haemostasis parameters in young and old mice. Young (10
weeks) and old (20 months) mice were placed in an urban
roadside tunnel or in a clean environment for 25 or 26 days.
They found in old mice that subchronic exposure to polluted
air raised platelet numbers, von Willebrand factor, soluble
P-selectin, and microvesicles, collectively substantiating
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a further elevation of thrombogenicity, already high at old
age [136].
There is a potential for neurodegenerative consequence
of particle entry to the brain. Histological evidence of
neurodegeneration has been reported in both canine and
human brains exposed to high ambient PM levels, suggesting
the potential for neurotoxic consequences of PM entry [137,
138]. PM-mediated damage may be caused by the oxidative
stress pathway which can enhance the susceptibility for
neurodegenerative diseases. The relationship between PM
exposure and central nervous system degeneration can also
be detected under controlled experimental conditions [137,
138]. Morphometric analysis of the central nervous system of
ApoE−/− mice exposed to concentrated ambient air pollution
showed that the brain is a critical target for particulate
air pollution exposure and implicated oxidative stress as
affecting factor that links PM exposure and susceptibility to
neurodegeneration [137, 138]. Further experimental studies
are needed to clarify the effect and mechanisms underlying
the neurotoxicity of particulate air pollution.
4. In Vitro Studies
In vivo models give a good insight of the toxic effects
of particles, and considering the multiple interactions of
different cell types in the lung, the complex responses are
well documented, but the cellular mechanisms related to the
specific responses become very difficult to clarify. In this
regard, the in vitromodels are used as a main tool to evaluate
the cellular mechanisms related to the exposure to particles.
There are several approaches to evaluate the toxic effects
of particles on cells that have been suggested or pointed
as targets of PM and NP. Single cell cultures, cocultures,
multiple cocultures, exposure under submerged conditions,
and exposure under air-liquid interface are among the main
strategies. We are discussing some of the most significant
advances on the evaluation of PM in vitro toxicology. In
Table 2, we summarize the most relevant in vitro evidence
supporting the observed in vivo effects.
4.1. Particle Properties Linked to Primary Cell Interaction. In
the lung, the particles may interact with the lung lining fluid
and the epithelial cells. In addition the particles may be taken
up by macrophages and other immune cells by phagocytosis
or pinocytosis. The interaction of particles with the cellular
plasma membrane and its receptors and ion channels may
directly trigger a biological response. The important DEP-
induced reactions often start from constituents leaking from
the particles including metals and various PAHs, including
derivatives like nitro-PAHs and various oxo-PAH (quinones).
The relative position of such components on the particle is
most likely of importance since just adding back extracted
components may result in less effects than the native particle
exerts [139]. Furthermore, the combination of particle con-
stituents like endotoxins and chemicals in organic fraction
may elicit more than additive cytokine response effects [15].
On the other hand, with regard to genotoxic effect, the
Table 2: In vitro evidence that supports and provides plausible
mechanisms for the in vivo observed effects induced by PM and NP.
In vitro evidence supporting the observed in vivo effects
In vivo observed effect In vitro evidence
Oxidative stress ROS increases via NADPH-oxidasein lung epithelial cell exposed to PM.
Local and systemic
inflammation
Secretion of IL-1b, IL-6, IL-8, TNFa,
MCP-1, and so forth, by lung cells,
macrophages, and cocultures.
Hyperplasia Proliferative stimuli induced byextracts of DEP components.
COPD Increased cytotoxicity on exposedcell cultures.
Systemic and endothelial
dysfunction
Endothelial cell activation by direct
contact with particles or indirectly
induced in cocultures where
pneumocytes, macrophages,
and other cell are exposed.
Particle translocation
Changes in the TEER values related
to tight junctions
Macrophage-dendritic
transepithelial cells network
alterations in the GJIC.
response will be higher in the extracts as more of the
carcinogenic PAH will be available to the cells [140, 141].
Although particle uptake in epithelial cells has also been
reported to occur [142], most biological responses triggered
by particles in these cells do not seem to depend on particle
uptake [143]. Particles as such have been reported to trigger
biological effects via acellular reactive oxygen species (ROS)
formation. However, DEP-induced immune responses in
A549 cells were reported to depend on activation of cellular
ROS-formation via the NADPH oxidase [144]. Furthermore,
emerging evidence suggests that particle constituents are
able to bind to or otherwise activate various membrane
and cytosolic receptors. Obviously, both AhR-ligand binding
as well as reactive electrophilic PAH metabolites covalently
binding to DNA are caused by chemical constituents released
from the particle [143, 145].
4.2. In Vitro Studies with Implications to Various PM-Induced
Cardiovascular Effects and Various Lung Diseases Including
Cancer. As we have seen in previous sections, damage of the
lung epithelial lining may have important implications with
regard to pathogen diseases, asthma, and allergy. Direct or
indirect induced chronic inflammation is also considered to
be central element in various cardiovascular diseases, COPD,
and a likely part of cancer development.
Regarding the latter, there is growing evidence suggesting
that air pollution exposure increases risk of lung cancer
[146, 147]. The components generally considered being of
most interest for such effects are particles in the ultrafine
(PM
0.1
) and fine fraction (PM
2.5
) including DEP and wood
smoke particles (WSP) [148]. However, more recent in vitro
evidence indicates that also the larger PM
10
particles might
play a role in cancer development through mechanisms
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such as damage to the lung epithelial cells, disruption of
tight junction and gap junction, effects of cell proliferation
including cytotoxicity, release of inflammatorymediators like
chemokines and cytokines, changes in gene expression via
receptor binding, and various forms of cellular DNA damage,
including epigenetic changes. It is also possible to study
in vitro effects of particle exposure on the later stages of
cancer development like chromosomal instability and cell
migration, which are important parts of tumor promotion
andmetastasis.However, we are not aware of that such studies
have been published.
4.2.1. Tight Junction. Tight junctions between the epithelial
cells represent an important barrier for the body protecting
the rest of tissue and organs from exposure to various
pathogenic intruders like virus, bacteria, fungi, air pollution
PM, and various particle-bound allergens. Exposure to such
components can result in infections and allergic/asthmatic
reactions. If combined with PM exposure, the end result
may be more chronic inflammatory reactions, which is
considered to be an important part of many pulmonary
diseases including COPD and cancer development. Geys and
coworkers showed that the transepithelial electrical resistance
(TEER) is linked to the tight junctions and the correlation
between the TEER value and the translocation of particles
through cellular monolayers [149]. Using an in vitro triple cell
culturemodel consisting of human epithelial cells (16HBE14),
monocyte-derived macrophages and dendritic cells, it was
recently demonstrated that macrophages, and dendritic cells
create a transepithelial network between epithelial cells to
capture antigens without disrupting the epithelial tightness
[150]. Using a similar model, Lehmann and coworkers [151]
observed that a high concentration of DEP (NIST 2975,
125 𝜇g/mL) canmodulate the tight junction occludingmRNA
in the cells of the epithelial defense system. In this connection,
it is also interesting to note that NIST 2975 DEPs have been
reported to increase the release of metalloproteinase MMP-
1 from human lung epithelial cells (A549 and NCI-H292).
MMP-1 is involved in the degradation of collagen and can
thus damage the lung epithelial barrier [144]. These findings
suggest that DEP can contribute to structural changes in the
epithelial liningwith inflammatory and possible carcinogenic
implications.
4.2.2. Gap Junction Intercellular Communication (GJIC).
GJIC is one way of intercellular exchange of low molecular
weightmolecules between adjacent cells. Chemically induced
alterations in this type of communication have been found to
result in abnormal cell growth and behavior and is considered
to be an interesting assay for in vitro studies of chemicals
that may act as tumor promoters [152]. Bay/bay-like regions
of PAH have been reported to be potent inhibitors of GJIC
[153]. Interestingly several high molecular weight PAHs with
known strong carcinogenic properties possessed only weak
(dibenzopyrenes) or no inhibition potency (dibenzofluoran-
thenes, naphtho[2,3-a]pyrene, and benzo[a]perylene) [154].
Furthermore, the PAH-induced inhibition of GJIC occurs
in the absence of PAH metabolism and aryl hydrocarbon
receptor (AhR) binding [155]. More probably, unmetabolized
PAH changes GJIC through direct interaction with unknown
factor(s) in the cellular membrane. In line with this, DEP has
been reported to inhibit GJIC [156–158].TheGJIC-effects of a
fractionatedDEP extract were found to be due to components
in the polar fraction, while the less polar nitro-PAH fraction
showed the strongest mutagenic potential (Ames test) [158].
4.2.3. Cell Proliferation and Cytotoxicity. Measuring cellular
proliferation and cytotoxicity has been used as one of the
primary toxicity tests for particulate matter [15, 16, 159].
With relatively simplemethods, differences in the intensity of
cytotoxicity have been demonstrated. Equal masses of urban
PM collected in different cities, or within a large city, asso-
ciated with different sources presented differences in cellular
proliferation and cytotoxicity [16, 17]. These results were of
main interest to evaluate the role of different components
of the toxic effects of particles and therefore identifying
components such as endotoxin, organic carbon, and some
elements, as the components associated to the cytotoxicity
[14, 16, 17].
Increased cytotoxicity is often followed by proliferative
stimuli considered to be of great importance for both fix-
ation of the primarily DNA lesion as well as for tumor
promotion phase. A number of compounds in DEP are
cytotoxic; other compounds are known to be DNA dam-
aged thus resulting in G1-arrest and/or accumulation in S-
phase due to reduced DNA synthesis [160, 161]. However,
DEPs also include compounds which may affect cell pro-
liferation in other ways. Two nitrophenols isolated from
DEP 3-methyl-4-nitrophenol (4-nitro-m-cresol, PNMC) and
4-nitro-3-phenylphenol (PNMPP) have been reported to
have estrogenic and antiandrogenic activities. Most inter-
estingly, proliferation of MCF-7 cells was stimulated by
PNMC, PNMPP, and estradiol-17beta and the antiestrogens
4-hydroxytamoxifen and ICI 182,780 inhibited the prolifer-
ation [162]. Crude extract of DEP exhibited both estrogenic
and antiestrogenic activities. Estrogenic activity of crude
extract and some fractions was induced through estrogen-
receptor- (ER-) mediated pathways. In particular, the acid
polar fraction of DEPs, which contains phenols, induced
high levels of estrogenic activity compared to other fractions
[163].
An important part of the known carcinogens found on air
pollution particles is various PAHs. Some of these have also
been reported to have mitogenic potency. More specifically,
weak mitogenic effects have been reported, suggested to
occur via increased Ca2+, activation of epidermal growth fac-
tor receptor (EGFR) and insulin receptor [164–167]. Further-
more, disruptions of contact inhibition via AhR-dependent
induction of JUN-D/cyclin [168] have been observed. This
type of effect obviously would also result in increased cell
proliferation. Most interestingly, it is known for a while that
several of these have so-called “stealth properties” [169–171].
This is a property by which reactive metabolites are able to
covalently bind to the DNA without easily being detected by
the cells defense system.More specifically, some reactive PAH
metabolites bind to DNA without triggering a G1-arrest. An
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increase in p53 seems to be induced but not a p21waf1/cip1-
inhibition of p53 transcriptional activity. Furthermore, some
PAH seems to induce mdm2 which may reduce the p53
activation [172, 173]. AhR-dependent inhibition of E2F1-
dependent apoptosis [174] reduced p53 nuclear translocation,
stimulation of cell survival signals, and inhibition of DNA
damage induced apoptosis have been reported after exposure
to certain PAH [175, 176]. Most importantly, such chemicals
would change the balance between cell death and cell survival
and cell proliferation following a DNA damaging event.
If not compensated with increased DNA repair, the end
result would necessarily be increased formation of mutation.
Furthermore, reactivemetabolites that react to a larger degree
with DNA than other macromolecules in the cells will have a
higher mutagenic potential [177, 178]. In line with this, it has
recently been reported that several environmental pollutants
including the carcinogenic PAH benzo[a]pyrene may change
plasma membrane characteristics, thereby altering cell phys-
iology and the balance between life or death of a cell [179].
4.2.4. Inflammatory Mediators. Several cytokines have been
found to function as proliferation and/or survival factors,
for example, IL-6, IL-8, and IL-1𝛽 [180] and which may
have implications for several lung diseases including cancer
development. Thus, a number of studies in vitro have elu-
cidated the inflammatory potential of various air pollution
particles [181]. In studies with BEAS-2B bronchial epithelial
lung cells DEP from a pre year 2000 engine increased the
release of chemokines such as IL-8 [182]; whereas EURO-4
DEP-induced typically IL-6 and IL-8, but also to a certain
degree CCL5, CXCL10, and IL1𝛽 [139]. Increased CCL5
(RANTES) after DEP exposure (pre year 2000 engine) has
also been reported by Hashimoto et al. [183]. Often the
induced expression and release of pro-IL-1𝛽 found to be
due to a combination of endotoxins and other particle
components [184]. In general, oxidative stress is considered
an important mechanism of particle-induced toxicity and
inflammation [181] in addition to other pathways of particle
effects. Direct ROS-formation by DEP may arise from enzy-
matic metabolism of organic compounds such as PAHs or
directly [185, 186]. Possible mechanisms also include a direct
activation of the membrane bound NADPH oxidase enzyme,
inducing the formation of ROS near the plasma membrane
[187]. A correlation between NADPH oxidase activation and
proinflammatory response has been reported using both in
vitro and in vivo systems exposed to air particles [188]. As
seen typically in studies of air pollution collected from cities,
there seems to be large seasonal differences in PM
10
and
PM
2.5
both with regard to chemical composition and their
biological effects as measured as proinflammatory cytokine
release and cytotoxicity [184]. The summer PM
10
exhibited
a higher proinflammatory potential, partly due to biological
components such as LPS as also previously reported by others
[189, 190]. Typically induced cytokines reported include IL-
6, IL-8, and IL-1𝛽. However, it should be emphasized that
no simple mechanism exists that explains all cellular effects,
and in some cases contradictory results have been observed
for IL-6 and IL-8 [191]. Furthermore, oxidative stress alone
seems to be insufficient to induce proinflammatory responses
in lung cells, pointing also to other mechanisms [192, 193].
Moreover, the mechanisms of particle-induced toxicity are
likely to change with increasing concentrations.
Of particular interest, recent studies show that DEP may
induce Ca2+ influx through proteinase-activated receptor-2
(PAR-2) mediated activation of TRPV4 channels in human
bronchial epithelial cells. This effect is probably linked
to IL-8 responses in bronchial epithelial cells induced by
multiple compounds found in ambient air [194]. Studies
also suggest that DEP exposure activates EGFR signaling
[194]. The activation of EGFR signaling through cleavage
and release of membrane bound transforming growth factor
(TGF-𝛼) by the metalloproteinase TNF𝛼 converting enzyme
(TACE or ADAM17) seems to be a universal mechanisms
of IL-8 regulation in airway epithelial cells by multiple
endogenous and exogenous compounds, including DEP and
various air pollution components [194]. It is also possible
the particle/DEP-linked formation of reactive metabolites
more directly could interfere with various cell signaling
pathways or effect organelles, thereby initiating inflammatory
reactions.
The vascular endothelium plays a central role in the
inflammatory process and cytokine production, and various
cellular signaling pathways trigger this response. Considering
the evidence that particulate matter can translocate from the
lungs within few minutes after exposure [85], the inflamma-
tory signal could reach the vascular endothelium by direct
exposure to particles. In this regard, several studies have
shown that PM and NP induce endothelial dysfunction after
exposure [16, 195–198]. The expression of early (E-Selectin,
P-Selectin) and late adhesion molecules (ICAM-1, VCAM-
1, PECAM-1) was associated with the presence of endotoxin
[199], the size of the particles [200], and the oxidative stress
induced by the particles and nanoparticles [201, 202]. Despite
the evidence provided by these studies, there is no certainty
of the amount of particles that can translocate, and there-
fore, the experimental conditions of exposure are always of
concern.
In vivo, the epithelial cells ormacrophages, or any cell that
is interacting with a particle, have an interaction with other
cell types, and those interactions may exacerbate or inhibit
the inflammatory response.Therefore, the single cell cultures
have the limitation of not evaluating those interactions.
Cocultures of two or more cell types may help to improve
the in vitro studies. A study using multiple cell cocultures
of human lung epithelial cells, macrophages, mast cells, and
endothelial cells demonstrated that when cocultures were
exposed, a stronger cytokine production was observed in
comparison to the responses obtained on single culture [203].
These types of models help to evaluate if the first contact of
PM orNPwith relevant cells is enough to induce an endothe-
lial activation that may lead to systemic effects. In this regard,
a modification of the model described by Alfaro-Moreno et
al., using a coculture where the endothelial cells and epithelial
cells are seeded on both sides of a membrane, demonstrated
that by exposing the epithelial cells, an activation of the
endothelial cells was evident within 24 h of exposure [204].
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It is interesting to note that inflammatory diseases
like asthma and COPD have been suggested to confer an
increased risk of lung cancer, although this implication may
not be straightforward [199, 200]. The hypothesis is based
on that the release of inflammatory mediators (chemokines
and cytokines) like IL-1𝛽 directly or via increased cyto-
toxicity (release of DAMP molecules) may result in an
increased number of neutrophils/macrophages in the lung.
Thus, several in vivo studies on other chemicals have reported
that the recruitment of such cells will result in increased
release of ROSmolecules that might exacerbate the increased
toxicity and thereby amplify the inflammatory process. Aug-
mented inflammation in a tissue will increase the oxida-
tive/nitrosative stress and lipid peroxidation (LPO), thereby
further generating excess ROS, reactive nitrogen species, and
DNA-reactive aldehydes. Miscoding etheno- and propano-
modified DNA bases are generated interalia by reaction of
DNA with these major LPO products [201]. The resulting
highly cytotoxic environment will also create surroundings
that favor selection of cells with mutations in p53, making
them more resistant to cell death [202]. Additional putative
mechanisms include impaired or imbalanced DNA repair
pathways. In this way, persistent oxidative/nitrosative stress
and excess LPO are induced by inflammatory processes in
a self-perpetuating process and cause progressive accumula-
tion ofDNAdamage in target organs including the lung [201].
However, the role of particle-induced inflammation in
lung cancer development is very complex. During the latest
years, it is becoming increasingly clear that cytokines and
chemokines can have a profound role in not only progression,
but also rejection of tumors [205].
4.2.5. Changes in Gene Expression via Receptor Binding. Cer-
tain changes in phenotypes might give increased probability
to development into cancer cells. Regarding exposure to
urban air particles, it is well known that some of these like
DEP and wood initiate various AhR responses [145, 161,
206]. This is explained by the fact that potent AhR ligands
such as PAH and dioxins are released from the particles.
The activation of the AhR results in increased metabolism
of xenobiotics, and changes in the balance between several
metabolic and detoxification pathways are often seen [177].
These types of changes may have important implications for
the cells, as more or less reactive metabolites are central for
cancer initiation, promotion and for inflammatory reactions.
Furthermore, this receptor has also very important physi-
ological functions that extend beyond specific metabolism
of xenobiotic, including effects on proliferation, contact
inhibition and migration, and immune regulation [145]. All
these process may have important implication for cancer
development.
4.2.6. Epigenetic Changes. Gene transcription is activated
when specific CpG sites are demethylated and histones are
acetylated, and, conversely, silenced when sites are methy-
lated and histones deacetylated. Furthermore, in addition to
oncogenes, tumor suppressors and miRNAs are the major
regulators of signaling in the cancer phenotype [207, 208].
Thus, possible implications of air pollution particle-induced
epigenetic changes should clearly be explored in vitro systems
as these endpointsmay become important biological markers
for epidemiological studies in the future.
4.2.7. Genotoxicity. It is well documented that different types
of particles, their extracts as well as single components
attached have genotoxic effects in human and animal studies
in vivo [209] as well as in vitro. After exposure of cells
in culture to different types of PM, several studies have
shown that cells may be arrested in various parts of the
cell cycle [160, 161, 210, 211]. Most often, such effects have
been linked to DNA damage. Various forms of DNA dam-
age have been reported after exposure to PM. The DNA
damage includes DNA single-strand breaks, alkali-labile
single-strand DNA breaks, and various forms of oxidative
DNA damage including oxidized guanines measured as 8-
oxo-7,8-dihydroguanine (8-oxoGua) and lesions detected as
formamidopyrimidine DNA glycosylase (fpg) sites by the
comet assay [161, 205]. Often this type of damage is associated
with the formation ofmicronuclei and chromosomal damage.
In line with this, positive effects of DEP on chromosome
aberration and sister chromatid exchange have been reported
in V79 cells without any additional activation system added
[212]. The organic extract of PM
2.5
was reported to generate
DNA breakage and micronucleus formation using BEAS-
2B cells as a model system. Testing of various fractions in
comet assay with fpg in this system suggested a possible
role of ROS and that aliphatic/chlorinated hydrocarbons,
PAH/alkylderivatives, and nitro-PAH/ketones/quinonesmay
be important causative agents of the genotoxic effects [213].
Furthermore, it should be noted thatDEP-extractable organic
matter (EOM) has been reported to have a substantial higher
capacity than the individual classic carcinogenic PAH with
regard to induce oxidative damage to DNA in HepG2 cells
[214].
While many reports focus on DNA breaks and/or
oxidative-DNA damage with regard to cancer development
[209], others link the PM-induced genotoxic and carcino-
genic effect to the “classic” carcinogenic PAH giving rise
to DNA adducts, often analysed by the 32P postlabelling
study [214]. Such PAH needs to be metabolically activated
to reactive, electrophilic metabolites that covalently bind to
DNA. Both acellular as well as various cells in vitro are
used. The adduct levels formed are linked to PAH levels
in extracts, fractionated extracts, or single PAH compound
tested separately [214]. The results from such studies indicate
that most DNA adducts detected in cells incubated with
extractable organic matter (EOM) from ambient air have
their origin in the low concentrations of carcinogenic PAH
representing a very low part of EOM total mass (0.03–
0.17%; [199]). In general, the bulky DNA adducts are more
often associated with high potency to form gene mutations,
considered to be of particular important for the initiation
phase of cancer development.
An important point in evaluating genotoxic potential is
the use of a metabolic activation system with sufficient ability
and capacity to activate these carcinogenic PAHs. Certain
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types of lung epithelial cells (e.g., Clara and type II) in vivo
have a relatively high level of CYP enzymes due to exposure
to AhR ligands (various PAH, dioxins) linked to ambient
air particles. Accordingly, several publications have shown
DNA adducts, DNA breaks and oxidative DNA damage(s)
after exposure to ambient particles [215–218]. Thus, lung
epithelial cells will in the in vivo situation have a clear capacity
to activate various carcinogenic compounds including PAH.
However, in contrast, the various lung epithelial cell lines as
well as primary lung cells from laboratory animals used in
vitro have amuch lower capacity to activate such compounds.
Such cells are thus, not always, the best choice to use
when testing for genotoxic effects of various ambient air
particle types. Interestingly, some liver-derived cell lines seem
to have a more interesting capacity to metabolic activated
PAH somewhat more similar to human in vivo situation;
although metabolic enzyme profile in liver will be different
compared to lung. Such models have nevertheless been
suggested to represent better in vitromodels for investigating
the genotoxic potential of complex mixtures containing PAH
[214, 219]. Another important aspect is to use a test system
that can detect the primary DNA damage of importance.
This could include technique such as the 32P postlabeling
technique to detect the larger and bulky DNA adducts. In
order to detect and evaluate DNA damaging constituents
which causes smaller DNA adduct/and other DNA lesions,
the comet assay with or without addition of fpg is a good
supplement [220].
Although not presently in use, it is possible to test the
capacity of particles and their extracts to transform epithelial
cells in vitro, representing a test of both “initiating” as well
as tumor “promoting” properties. In a transformation assay
using BALB/c 3T3 cells, DEPs have reported to cause mor-
phological transformation [212]. Similarly, it was reported
that DEP and two related compounds, 1-nitropyrene (1-NP)
and dibenzo(a,i)pyrene (DBP), are capable of transforming
rat tracheal epithelial cells [221]. Various coculture systems
also add important information to the problem of a “relevant
metabolic activationmodel” when testing genotoxic effects of
PM in vitro. In a recent study, results supporting the notion
that highly reactive benzo[a]pyrene (B[a]P) derived metabo-
lites produced within human alveolar macrophage could be
transferred to a secondary target epithelial cell line were
presented [222]. Such findings have in addition important
in vivo implications when explaining possible mechanisms
involved in ambient air induced lung cancer. By using DNA
repair capacity in vitromany important aspects of the role of
DNA repair in maintaining genetic stability and preventing
carcinogenesis can be elucidated [223]. Furthermore, studies
and analyses of polymorphisms ofDNA repair genes involved
in nucleotide excision repair (NER) may turn out to be
useful biomarkers to identify individuals susceptible to DNA
damage resulting from ambient air exposure [224]. Also
the level of proteins involved in the DNA response like
gamma-H2AX, p53, and p21 (WAF1) protein levels has been
analyzed and linked to PM-induced genotoxic and cytotoxic
effects [161, 225]. Most interestingly, it has been reported that
ambient air PM greatly inhibits nucleotide excision repair
(NER) for ultraviolet (UV) light and benzo[a]pyrene diol
epoxide (BPDE) induced DNA damage in human lung cells.
PM increased both spontaneous and UV-induced mutage-
nesis, suggesting that the carcinogenicity of PM may act
through its combined effect on suppression of DNA repair
and enhancement of DNA replication errors [226].
5. Conclusions
Urban air pollution consists of an extremely complexmixture
of gaseous and particulate agents. The majority of published
studies concur to the statement thatwhilst gaseous pollutants,
such as ozone or SO
2
, play a significant role, the unifying
element of the adverse health effects of urban air pollution
consists of respirable PM [1, 88]. Many studies using animal
models have been performed to elucidate PM effects in
different organs, in relation to different diseases.With respect
to acute effects, most studies have focused on inflamma-
tory responses, and relatively few studies have included
more disease-specific responses, perhaps with the exception
of studies on allergy-related responses. In contrast more
studies on chronic effects have elucidated disease-related
processes, such as DNA damage, lung parenchyma destruc-
tion, increased plaque volume in arteries, lung fibrosis, or
granuloma formation. An increased focus on more direct
disease-related parameters in models that closely resemble
the human disease pattern would improve the usefulness of
the in vivomodels.
Since the in vitro models prove themselves to be most
useful to study mechanistic responses, such as initiation
events of inflammatory effects or genotoxicity, it would be
of interest for the interpretation of results if the in vivo
studies could also to a greater extent cover mechanistic
effects, to discover a possible coherence of results with the
in vitro studies. Whereas the relationship between some in
vitro end points, particularly with respect to genotoxicity
and indicators of cancer development and disease, has been
established; with respect to other end points, this relationship
has not been fully developed. Improved in vitro models that
seek to cover this field need to be further developed.
The in vitro models have proven useful in studying the
importance of a range of particle sizes and components. For
example, evidence suggests that the ultrafine fraction of these
particles shows more toxicity at equal mass concentrations
compared to larger particles, because of their increased
reactivity, surface area, and particle number on a mass basis.
Furthermore, a coherence of certain in vitro cellular effects
and responses in biopsies from human volunteers has been
shown for the exposure to diesel exhaust particles [194, 227].
On the other hand, sometimes very high concentrations used
in in vitro models suggest caution in the interpretation of in
vitro results and again points to the development of more
sensitive models.
Nanotechnology develops products with highly different
physical and chemical properties, and they are also used in
a variety of areas such as diagnosis, imaging, drug delivery,
information, and communication technologies, and their
extensive use in the consumer and industrial products is just
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beginning to emerge [87]. Thus, in order to cope with such a
variation of type of material and use, structure activity and in
vitro studies will be of help [87].
The increased risk of respiratory and cardiovascular
diseases requires additional toxicological studies to be per-
formed and specific measures to be taken for environmental
PM and newly developed engineered NP.
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